According to Santen Pharmaceutical 's latest financial reports the company's current EPS (TTM) is -$0.19. In 2022 the company made an earnings per share (EPS) of -$0.12 a decrease over its 2021 EPS that were of $0.17.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.19 | 59.97% |
2022 | -$0.12 | -172.6% |
2021 | $0.17 | -71.16% |
2020 | $0.58 | -12.81% |
2019 | $0.66 | -5.39% |
2018 | $0.70 | -0.15% |
2017 | $0.70 | 49.24% |
2016 | $0.47 | -58.85% |
2015 | $1.14 | 138.45% |
2014 | $0.48 | 10.85% |
2013 | $0.43 | -9.52% |
2012 | $0.48 | -23.1% |
2011 | $0.62 | 31.24% |
2010 | $0.47 | 0.99% |
2009 | $0.47 |